Clearstead Trust’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.14M | Buy |
6,676
+34
| +0.5% | +$34.5K | 1% | 21 |
|
|
2025
Q4 | $7.14M | Sell |
6,642
-84
| -1% | -$80.3K | 1.12% | 18 |
|
|
2025
Q3 | $5.13M | Buy |
6,726
+1,866
| +38% | +$1.39M | 0.88% | 17 |
|
|
2025
Q2 | $3.79M | Buy |
4,860
+57
| +1% | +$44.3K | 0.72% | 22 |
|
|
2025
Q1 | $3.97M | Sell |
4,803
-69
| -1% | -$57.4K | 0.88% | 21 |
|
|
2024
Q4 | $3.76M | Sell |
4,872
-249
| -5% | -$206K | 0.81% | 22 |
|
|
2024
Q3 | $4.54M | Buy |
5,121
+33
| +0.6% | +$29.7K | 1.09% | 19 |
|
|
2024
Q2 | $4.61M | Buy |
5,088
+183
| +4% | +$146K | 1.15% | 17 |
|
|
2024
Q1 | $3.82M | Buy |
4,905
+654
| +15% | +$465K | 1% | 22 |
|
|
2023
Q4 | $2.48M | Buy |
4,251
+744
| +21% | +$434K | 0.68% | 27 |
|
|
2023
Q3 | $1.88M | Hold |
3,507
| – | – | 0.62% | 30 |
|
|
2023
Q2 | $1.52M | Hold |
3,507
| – | – | 0.49% | 36 |
|
|
2023
Q1 | $1.2M | Sell |
3,507
-248
| -7% | -$83.6K | 0.38% | 53 |
|
|
2022
Q4 | $1.37M | Buy |
3,755
+248
| +7% | +$87.9K | 0.46% | 41 |
|
|
2022
Q3 | $1.13M | Buy |
3,507
+2,507
| +251% | +$794K | 0.39% | 43 |
|
|
2022
Q2 | $324K | Hold |
1,000
| – | – | 0.25% | 59 |
|
|
2022
Q1 | $286K | Hold |
1,000
| – | – | 0.19% | 69 |
|
|
2021
Q4 | $276K | Hold |
1,000
| – | – | 0.16% | 77 |
|
|
2021
Q3 | $231K | Hold |
1,000
| – | – | 0.15% | 85 |
|
|
2021
Q2 | $230K | Buy |
+1,000
| New | +$201K | 0.15% | 84 |
|
|
2021
Q1 | – | Sell |
-1,000
| Closed | -$169K | – | 136 |
|
|
2020
Q4 | $169K | Hold |
1,000
| – | – | 0.1% | 102 |
|
|
2020
Q3 | $148K | Hold |
1,000
| – | – | 0.12% | 93 |
|
|
2020
Q2 | $164K | Hold |
1,000
| – | – | 0.14% | 92 |
|
|
2020
Q1 | $139K | Hold |
1,000
| – | – | 0.13% | 96 |
|
|
2019
Q4 | $131K | Hold |
1,000
| – | – | 0.1% | 107 |
|
|
2019
Q3 | $112K | Hold |
1,000
| – | – | 0.09% | 109 |
|
|
2019
Q2 | $111K | Hold |
1,000
| – | – | 0.09% | 111 |
|
|
2019
Q1 | $130K | Hold |
1,000
| – | – | 0.11% | 106 |
|
|
2018
Q4 | $116K | Hold |
1,000
| – | – | 0.11% | 113 |
|
|
2018
Q3 | $107K | Hold |
1,000
| – | – | 0.08% | 111 |
|
|
2018
Q2 | $85K | Buy |
+1,000
| New | +$82.1K | 0.08% | 120 |
|
|
2018
Q1 | – | Sell |
-1,000
| Closed | -$84K | – | 157 |
|
|
2017
Q4 | $84K | Hold |
1,000
| – | – | 0.06% | 133 |
|
|
2017
Q3 | $86K | Hold |
1,000
| – | – | 0.06% | 145 |
|
|
2017
Q2 | $82K | Buy |
+1,000
| New | +$81.6K | 0.06% | 136 |
|
Other funds holding LLY
VCM
VPM
Clearstead Trust's LLY Position: Q1 2026 in Review
Clearstead Trust increased its Eli Lilly (LLY) stake by 0.51% in Q1 2026, buying an estimated $34.5K and bringing the position to 6,676 shares worth $6.14M. The position accounts for 1% of the portfolio, ranked #21.
Clearstead Trust first reported a position in LLY in Q2 2017 and has held it in 34 quarters since. The position peaked at $7.14M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Clearstead Trust held 6,676 shares of Eli Lilly worth $6.14M as of Q1 2026.
- Clearstead Trust bought 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
- Eli Lilly made up 1% of Clearstead Trust's portfolio in Q1 2026, its #21 holding.
- Clearstead Trust first reported a position in Eli Lilly in Q2 2017 and has held it in 34 quarters since.
- Clearstead Trust's Eli Lilly position peaked at $7.14M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.